Alyssa LaBelle

Statistics

Publications

Citations

290

H-Index

Active since

2014

Affiliations

ImmunoGen (United States)(Current)

Alyssa LaBelle is an author at ImmunoGen (United States) specializing in targeted cancer therapy, antibody-drug conjugate therapy, and antibody-drug conjugate antibodies.

Publications per year

2014–2015

Publications

IMGN853, a Folate Receptor-α (FRα)–Targeting Antibody–Drug Conjugate, Exhibits Potent Targeted Antitumor Activity against FRα-Expressing Tumors

Olga Ab, Kathleen R. Whiteman, Laura M. Bartle et al. · Molecular Cancer Therapeutics · 2015 · 224 citations

Pharmacy, Oncology, Pharmacology +17

Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models

Kathleen R. Whiteman, Holly A. Johnson, Michele Mayo et al. · mAbs · 2014 · 66 citations · Full text

Medicine, Oncology, Pharmacology +17

1–2 of 2